Novo Nordisk A/S expected to post earnings of DKK4.60 a share - Earnings Preview - TradingView

Novo Nordisk A/S NOVO_B, NOVO_B is expected to show a rise in quarterly revenue when it reports results on November 5 for the period ending September 30 2025 The Bagsvaerd Denmark-based company is expected to report a 9.4% increase in revenue to DKK77.997 billion from DKK71.31 billion a year ago, according to the mean estimate from 6 analysts, based on LSEG data. ​LSEG's mean analyst estimate for Novo Nordisk A/S is for earnings of DKK4.60 per share. The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 4 "strong buy" or "buy," 4 "hold" and 2 "sell" or "strong sell." The mean earnings estimate of analysts was unchanged in the last three months. ​ Wall Street's median 12-month price target for Novo Nordisk A/S is $61.00, about 18.9% above its last closing price of $49.46